Home / Conferences / SMi Biosimilars and Biobetters 2017

SMi Biosimilars and Biobetters 2017 Posted 02/06/2017

Biosimilars and Biobetters 2017
27–28 September 2017
Holiday Inn Kensington Forum
London, UK

SMi Group is thrilled to present the 2017 8th annual conference on Biosimilars & Biobetters taking place on 27 and 28 September 2017 in Central London, UK.

As the patents for several innovator biologicals expire, biopharmaceutical companies are taking the opportunity to develop more affordable forms creating a rapidly booming biosimilars market. However, as the field of biosimilars evolves, challenges in immunogenicity studies, securing market share, exclusivity and regulations still persist. Created with a top panel of industry thought leaders, Biosimilars & Biobetters 2017 will tackle these challenges head on by honing in on current market trends, emerging opportunities and global developments.  Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and critical updates on interchangeability guidelines and patient litigation.

A must attend for principle scientists and regulatory experts involved in biotechnology, market access and compliance, this year’s event will feature expert insight from Boehringer Ingelheim, Celltrion Healthcare, QuintilesIMS, Merck Group, Norwegian Medicines Agency, Teva Pharmaceuticals, Biocon, Gedeon Richter, Prolong Pharmaceuticals, Lupin Europe and more! For details contact the team on +44 20 7827 6000 or email events@smi-online.co.uk

www.biosimilars-europe.com/gabilisting